BlueStar® Genomic Health Care Index
The BlueStar® Genomic Health Care Index (BDNA) tracks the performance of the largest and most liquid companies in the global genomic healthcare industry. This is a modified market cap-weighted index, and only includes companies that generate at least 50% of their revenue from health care therapies based on targeting or the modification of the genetic makeup of cells or uses mRNA, technology platforms that enable the development of genetics-based health care thearpies, or laboratory equipment or services used to test, code, or develop genetics-based health care companies.
This page compares selected fundamental data of the MVIS Index to designated peer indices. The data is updated monthly.
|Trailing Price/Earnings (incl. negative)||-7.08 |
|Trailing Price/Earnings (excl. negative)||10.09 |
|Price/Cash Flow||8.49 |
|Dividend Yield||0.03 |
|Net Debt to Equity||-0.10 |